Search

ABT-199: Novel Bcl-2 specific inhibitor updated results confirm substantial activity and durable responses in high-risk CLL.

Jun 13 2014 Posted in Press releases

Chronic Lymphocytic Leukaemia (CLL) is the most common leukemia in adults in the Western world and is diagnosed in approximately 5 persons per 100,000 population per year.

Substances of Human Origin (SoHO) legislation

EHA’s involvementEHA has been involved in both the evaluation and subsequent revision of the EU legislation on human blood and blood components. The evaluation of these rules, which dated back to 2002, began in 2016.

Guidelines Committee call for interest

The aim of the Guidelines Committee is to promote and support the creation and adoption of guidelines for diagnosis and treatment of hematologic diseases.

SWG Preceptorship Program

Funding to enable an SWG create its own preceptorship—and promote learning and innovation in our community. The call for proposals closed at 12:00 CEST on March 28, 2025.

6th European CAR T-cell Meeting

Dates: February 15-17, 2024
Location: Valencia, Spain
Format: Hybrid
Chairs: Michael Hudecek & Anna Sureda

Registration is closed. Those already registratered can view on-demand content via the platform until March 17.

EHA Meeting Hub

Book a free-of-charge space at EHA2025 where you can meet your colleagues and further your work in person. What is the EHA Meeting Hub?The EHA Meeting Hub is a bookable on-site space at the EHA Congress venue in Milan.

Can Eltrombopag help children with ITP say goodbye to bleeding?

Jun 13 2014 Posted in Press releases

Immune thrombocytopenia (ITP) is a rare disease in children, affecting 5 in 100,000. Most children get better quickly without intervention but up to 30% will still have disease at 12 months.